Learn how Baysient’s T3 application empowers gastroenterologists to optimize Ustekinumab treatment. This walkthrough demonstrates how T3 provides personalized dosing insights tailored to each patient’s unique characteristics, helping achieve therapeutic goals while minimizing risks.

Key highlights include:

✔ Generating individualized dosing strategies based on patient-specific data.

✔ Using visual simulations to track how dosing adjustments impact trough levels and treatment outcomes.

✔ Assessing probabilities for remission, CRP normalization, and antibody formation risk.

T3 simplifies complex dosing decisions, enabling healthcare providers to move beyond standard regimens and deliver personalized, effective care for patients with inflammatory diseases.